These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24841294)

  • 1. Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects.
    Lips MA; de Groot GH; Berends FJ; Wiezer R; van Wagensveld BA; Swank DJ; Luijten A; van Dijk KW; Pijl H; Jansen PL; Schaap FG
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):862-70. PubMed ID: 24841294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
    Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y gastric bypass and calorie restriction induce comparable time-dependent effects on thyroid hormone function tests in obese female subjects.
    Lips MA; Pijl H; van Klinken JB; de Groot GH; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Smit JW
    Eur J Endocrinol; 2013 Sep; 169(3):339-47. PubMed ID: 23811187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roux-en-Y Gastric Bypass Surgery Has Unique Effects on Postprandial FGF21 but Not FGF19 Secretion.
    Harris LLS; Smith GI; Mittendorfer B; Eagon JC; Okunade AL; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3858-3864. PubMed ID: 28938478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies.
    Lips MA; de Groot GH; De Kam M; Berends FJ; Wiezer R; Van Wagensveld BA; Swank DJ; Luijten A; Pijl H; Burggraaf J
    Eur J Endocrinol; 2013 Oct; 169(4):383-90. PubMed ID: 23847327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery.
    Jansen PL; van Werven J; Aarts E; Berends F; Janssen I; Stoker J; Schaap FG
    Dig Dis; 2011; 29(1):48-51. PubMed ID: 21691104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes.
    Lips MA; Van Klinken JB; van Harmelen V; Dharuri HK; 't Hoen PA; Laros JF; van Ommen GJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Dane A; Harms A; Vreeken R; Hankemeier T; Smit JW; Pijl H; Willems van Dijk K
    Diabetes Care; 2014 Dec; 37(12):3150-6. PubMed ID: 25315204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight loss induced by very low calorie diet is associated with a more beneficial systemic inflammatory profile than by Roux-en-Y gastric bypass.
    Lips MA; van Klinken JB; Pijl H; Janssen I; Willems van Dijk K; Koning F; van Harmelen V
    Metabolism; 2016 Nov; 65(11):1614-1620. PubMed ID: 27733249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
    Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
    Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?
    Crujeiras AB; Gomez-Arbelaez D; Zulet MA; Carreira MC; Sajoux I; de Luis D; Castro AI; Baltar J; Baamonde I; Sueiro A; Macias-Gonzalez M; Bellido D; Tinahones FJ; Martinez JA; Casanueva FF
    Int J Obes (Lond); 2017 Oct; 41(10):1570-1578. PubMed ID: 28588304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy restriction and Roux-en-Y gastric bypass reduce postprandial α-dicarbonyl stress in obese women with type 2 diabetes.
    Maessen DE; Hanssen NM; Lips MA; Scheijen JL; Willems van Dijk K; Pijl H; Stehouwer CD; Schalkwijk CG
    Diabetologia; 2016 Sep; 59(9):2013-7. PubMed ID: 27312699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.
    Sachdev S; Wang Q; Billington C; Connett J; Ahmed L; Inabnet W; Chua S; Ikramuddin S; Korner J
    Obes Surg; 2016 May; 26(5):957-65. PubMed ID: 26259981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction.
    Jones B; Sands C; Alexiadou K; Minnion J; Tharakan G; Behary P; Ahmed AR; Purkayastha S; Lewis MR; Bloom S; Li JV; Tan TM
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e767-e782. PubMed ID: 34460933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glucose metabolism after gastric bypass: evolution of the paradigm.
    Pournaras DJ; Nygren J; Hagström-Toft E; Arner P; le Roux CW; Thorell A
    Surg Obes Relat Dis; 2016; 12(8):1457-1465. PubMed ID: 27387696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Very Low-Calorie Diet versus Roux-en-Y Gastric Bypass Surgery on Body Composition in Patients with Obesity.
    Saiyalam C; Shantavasinkul PC; Chirnaksorn S; Rattanakaemakorn P; Taonam N; Rodphech V; Putadechakum S; Rattanasiri S; Sirivarasai J; Ongphiphadhanakul B; Sumritpradit P
    Nutrients; 2024 Jul; 16(15):. PubMed ID: 39125287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice.
    Morrison CD; Hao Z; Mumphrey MB; Townsend RL; Münzberg H; Ye J; Berthoud HR
    Mol Metab; 2016 Oct; 5(10):1006-1014. PubMed ID: 27689013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.
    Jørgensen NB; Dirksen C; Bojsen-Møller KN; Kristiansen VB; Wulff BS; Rainteau D; Humbert L; Rehfeld JF; Holst JJ; Madsbad S; Clausen TR
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E396-406. PubMed ID: 25536209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Effects of Gastric Bypass Surgery: Is It All About Calories?
    Herzog K; Berggren J; Al Majdoub M; Balderas Arroyo C; Lindqvist A; Hedenbro J; Groop L; Wierup N; Spégel P
    Diabetes; 2020 Sep; 69(9):2027-2035. PubMed ID: 32527768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased glucose-stimulated FGF21 response to oral glucose in obese nondiabetic subjects after Roux-en-Y gastric bypass.
    Vienberg SG; Jacobsen SH; Worm D; Hvolris LE; Naver L; Almdal T; Hansen DL; Wulff BS; Clausen TR; Madsbad S; Holst JJ; Andersen B
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):156-159. PubMed ID: 27649688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.